{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:39:44Z","timestamp":1772815184570,"version":"3.50.1"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1111\/bjd.14448","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T10:13:24Z","timestamp":1461752004000},"page":"718-719","source":"Crossref","is-referenced-by-count":8,"title":["Ustekinumab, another biologic with potential to help patients with hidradenitis suppurativa?"],"prefix":"10.1093","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6741-3182","authenticated-orcid":false,"given":"D.B.","family":"Eisen","sequence":"first","affiliation":[{"name":"Department of Dermatology; University of California Davis Medical Center; Sacramento CA 95816 U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,4,26]]},"reference":[{"key":"10.1111\/bjd.14448-BIB0001|bjd14448-cit-0001","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14448-BIB0002|bjd14448-cit-0002","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjd.12233","article-title":"Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support","volume":"168","author":"Danby","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14448-BIB0003|bjd14448-cit-0003","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.det.2015.08.004","article-title":"Inflammatory mechanisms in hidradenitis suppurativa","volume":"34","author":"Kelly","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1111\/bjd.14448-BIB0004|bjd14448-cit-0004","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jaad.2015.07.053","article-title":"Treatment of hidradenitis suppurativa with biologic medications","volume":"73","author":"Lee","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14448-BIB0005|bjd14448-cit-0005","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1111\/bjd.14448-BIB0006|bjd14448-cit-0006","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14448-BIB0007|bjd14448-cit-0007","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/rheumatology\/ken034","article-title":"Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register","volume":"47","author":"Karlsson","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/bjd.14448-BIB0008|bjd14448-cit-0008","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum","volume":"174","author":"Blok","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14448-BIB0009|bjd14448-cit-0009","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/bjd.14448-BIB0010|bjd14448-cit-0010","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","article-title":"Ustekinumab induction and maintenance therapy in refractory Crohn's disease","volume":"367","author":"Sandborn","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.14448-BIB0011|bjd14448-cit-0011","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1524-4725.2009.01214.x","article-title":"Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser","volume":"35","author":"Tierney","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.14448-BIB0012|bjd14448-cit-0012","unstructured":"NIHR Horizon Scanning Research & Intelligence Centre Ustekinumab (Stelara) for Plaque Psoriasis in Adolescents 2013 http:\/\/www.hsc.nihr.ac.uk\/topics\/ustekinumab-stelara-for-plaque-psoriasis-in-adolescents\/"},{"key":"10.1111\/bjd.14448-BIB0013|bjd14448-cit-0013","unstructured":"NIHR Horizon Scanning Research & Intelligence Centre Inflectra (Infliximab Biosimilar) for Psoriatic Arthritis 2013 http:\/\/www.hsc.nihr.ac.uk\/topics\/inflectra-infliximab-biosimilar-for-psoriatic-arthritis\/"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14448","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.14448\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:19:09Z","timestamp":1676384349000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/174\/4\/718\/6617898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.14448","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}